Rare diseases
Investigational molecules
Locations
Grosse Bleichen 12/14, Neustadt, 20354 Hamburg, Germany
Ferring Ventures GmbH is involved in clinical research focused on peripheral arterial disease with a specific emphasis on patients with chronic limb threatening ischemia, a severe vascular condition associated with impaired limb perfusion and difficult-to-heal tissue injury.
The sponsor’s research interest centers on therapeutic approaches relevant to limb preservation and the management of ischemic tissue damage.
Ferring Ventures GmbH runs clinical trials in conditions such as Peripheral arterial occlusive disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
